SCHEMBL106703

SCHEMBL106703

O=C(NCc1ccc(OC(F)(F)F)cc1)ON1CCN(CCC(=O)c2ccc3[nH]c(=O)oc3c2)CC1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 1/20 0.52
GRIN3B O60391 1/20 0.52
GRIN1 Q05586 1/20 0.52
GRIN2A Q12879 1/20 0.52
GRIN2B Q13224 1/20 0.52
GRIN2C Q14957 1/20 0.52
GRIN3A Q8TCU5 1/20 0.52
ENPP2 Q13822 7/20 0.51
KCNH2 Q12809 2/20 0.50
CREBBP Q92793 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
ATXN2 Q99700 1/20 0.38
MAPK8 P45983 1/20 0.38
MAPK10 P53779 1/20 0.38
SCN5A Q14524 1/20 0.38
SCN9A Q15858 1/20 0.38
HRH3 Q9Y5N1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL172140 0.89 ENPP2 (0.57) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL105007 0.88 ENPP2 (0.60) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL105662 0.87 ENPP2 (0.53) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL144780 0.86 ENPP2 (0.53) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL104988 0.85 ENPP2 (0.52) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL106235 0.85 ENPP2 (0.67) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL3054974 0.82 ENPP2 (0.77) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL15135277 0.78 ENPP2 (0.66) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL107319 0.76 GRIN2D (0.61) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL3055653 0.75 ENPP2 (0.65) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2426106-B1 Piperidine and Piperazine derivatives for the treatment of tumours MERCK PATENT GMBH (DE) 2013-07-31 EP claimed
EP-2426106-A1 Piperidine and Piperazine derivatives for the treatment of tumours Merck Patent GmbH (DE) 2012-03-07 EP claimed
EP-2426106-B1 Piperidine and Piperazine derivatives for the treatment of tumours MERCK PATENT GMBH (DE) 2013-07-31 EP disclosed
EP-2426106-A1 Piperidine and Piperazine derivatives for the treatment of tumours Merck Patent GmbH (DE) 2012-03-07 EP disclosed
EP-2193118-A2 PIPERIDINE AND PIPERAZINE DERIVATIVES FOR TREATING TUMOURS Merck Patent GmbH (DE) 2010-06-09 EP disclosed
WO-2009046841-A2 PIPERIDINE AND PIPERAZINE DERIVATIVES FOR TREATING TUMOURS MERCK PATENT GMBH (DE) 2009-04-16 WO disclosed